Cure51 is a pioneering initiative focused on unlocking the secrets of exceptional cancer survivors, known as "Outliers," who survive more than five years after a lethal cancer diagnosis. Co-founded with leading oncology centers worldwide, the organization's mission is to leverage the data from these rare patients with the long-term ambition to meaningfully accelerate progress against lethal cancers, what Cure51 describes as contributing to cancer eradication within the coming decade. By studying the biology of those who survive, Cure51 aims to use outlier biology to inform new targets, therapies, and precision tools that could improve outcomes across multiple lethal cancers, operating under the belief that miracles should be accessible to all.
Mission and Approach
• Focus: The organization concentrates on exceptional cancer survivors from all continents to build a unique clinical and multi-omics database.
• Contrasting Methodology: Unlike traditional oncology research that often studies the 99% of patients who succumb to lethal cancers, Cure51 focuses on the biology of the rare survivors.
• Core Belief: The initiative is built on the principle that these exceptional survivors are living proof that nature can beat cancer, and their data holds the key to future cures.
Global Network and Collaboration
• Global Reach: Cure51 has established one of the largest cancer networks in history, with collaborations spanning every continent.
• Institutional Partnerships: The organization was co-founded with and continues to collaborate with the world's leading cancer centers.
• Scientific Leadership: A Scientific Steering Committee composed of world-renowned oncologists guides the initiative's research and strategic direction.
Data-Driven Drug Discovery
• Data Collection: The primary activity involves identifying and collecting unique data from thousands of long-term cancer survivors.
• Computational Biology: A dedicated team works with scientific partners to discover multimodal signatures from the collected data.
• Therapeutic Development: The insights gained are used to create a library of robust targets, contributing to the design of best-in-class drugs and the development of precision medicine tools for novel therapeutics.
Community and Vision
• Collective Effort: The organization operates with the conviction that "The Collective Will Shape the Cure," emphasizing that healing requires a broad coalition.
• Inclusive Mission: Guided by the idea that "Life Leads the Way," Cure51 welcomes every perspective in its mission, including those from frontline caregivers, patients, researchers, and media voices.
By harnessing the power of data from those who have defied the odds, Cure51 is building a global coalition dedicated to transforming cancer treatment. The organization actively invites engagement from all sectors to join the conversation and contribute to the mission of defeating cancer for everyone.